EcoDrugPlus

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSCHYG00000018665
Gene Symbol: PSMA1
1 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSCHYG00000021589
Gene Symbol: PSMA2
1 Cross references
192 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSCHYG00000006862
Gene Symbol: PSMA3
1 Cross references
246 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSCHYG00000013011
Gene Symbol: PSMA4
1 Cross references
249 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSCHYG00000016083
Gene Symbol: PSMA5
1 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSCHYG00000025756
Gene Symbol: PSMA7
1 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSCHYG00000025804
Gene Symbol: PSMA8
1 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSCHYG00000026980
Gene Symbol: PSMB1
1 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSCHYG00000012898
Gene Symbol: PSMB10
1 Cross references
172 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSCHYG00000027060
Gene Symbol: PSMB2
1 Cross references
145 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSCHYG00000001228
Gene Symbol: PSMB3
1 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSCHYG00000006978
Gene Symbol: PSMB4
1 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).